cytarabine has been researched along with phenylephrine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Epstein, CJ; Gray, MO; Honbo, N; Karliner, JS; Lau, YF; Xian, M | 1 |
2 other study(ies) available for cytarabine and phenylephrine
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neonatal mouse cardiac myocytes exhibit cardioprotection induced by hypoxic and pharmacologic preconditioning and by transgenic overexpression of human Cu/Zn superoxide dismutase.
Topics: Adrenergic alpha-Antagonists; Alanine; Animals; Animals, Newborn; Bromodeoxyuridine; Cardiotonic Agents; Cell Survival; Cells, Cultured; Cytarabine; Female; Fibroblasts; Flow Cytometry; Gene Deletion; Humans; Hypoxia; Ischemic Preconditioning, Myocardial; Male; Mice; Mice, Transgenic; Myocardium; Norepinephrine; Oxidative Stress; Phenylephrine; Prazosin; Recombinant Fusion Proteins; Superoxide Dismutase; Time Factors; Transgenes; Vasoconstrictor Agents | 2000 |